DJIA 17,805.95 -4.11 -0.02%
NASDAQ 4,737.06 24.09 0.51%
S&P 500 2,066.84 3.34 0.16%
market minute promo

3.00 -0.02 (-0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

THLD $3.00 -0.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.01
Previous Close $3.02
Daily Range $2.98 - $3.05
52-Week Range $2.58 - $5.93
Market Cap $188.3M
P/E Ratio -6.04
Dividend (Yield) $0.00 (0.0%)
Volume 116,799
Average Daily Volume 781,105
Current FY EPS -$0.46

Sector

Healthcare

Industry

Drugs

THRESHOLD PHARMACEUTICALS, INC. (THLD) Description

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. Website: http://www.thresholdpharm.com/

News & Commentary Rss Feed

These 7 States Have the Highest Rates of Pancreatic Cancer

Pancreatic cancer is arguably the most lethal form of the disease. Find out which seven states this disease occurs in most often, as well as what new pathways are being tested to treat this terrible disease.

Health Care Sector Update for 11/17/2014: INO, THLD, AZN

US Futures Barely Higher Closer to Open; Alibaba Surpasses $8 Bln in Sales on Singles' Day Shopping

US Futures Barely Higher Closer to Open; Alibaba Surpasses $8 Bln in Sales on Singles' Day Shopping Day

Threshold Pharmaceuticals Receives FDA Fast Track Designation For TH-302 For The Treatment Of Previo

Threshold Pharmaceuticals Receives FDA Fast Track Designation For TH-302 For The Treatment Of Previously Untreated Patients With Metastatic Or Locally Advanced Unresectable Soft Tissue Sarcoma

Threshold Pharmaceuticals Announces New Phase 1/2 Data On TH-302 In Multiple Myeloma to Be Presented

Threshold Pharmaceuticals Announces New Phase 1/2 Data On TH-302 In Multiple Myeloma to Be Presented At The 2014 ASH Annual Meeting

Threshold Pharma Says Phase 3 Trial of TH-302 in Patients with Advanced Soft Tissue Sarcoma Will Con

Threshold Pharma Says Phase 3 Trial of TH-302 in Patients with Advanced Soft Tissue Sarcoma Will Continue as Planned

Apple Unveils Watch, Larger iPhones; Francesca's Shares Drop After Downbeat Results

Apple Unveils Watch, Larger iPhones; Francesca's Shares Drop After Downbeat Results

Threshold Pharmaceuticals, Inc. Shares Jump Amid H.C. Wainwright Initiation

Clinical Trial Results To Watch

See More THLD News...

THLD's Top Competitors

THLD $3.00 (-0.66%)
Current stock: THLD
AMGN $164.08 (0.78%)
Current stock: AMGN
GILD $100.21 (-0.37%)
Current stock: GILD
BIIB $306.68 (1.03%)
Current stock: BIIB